Diffusion MR Characteristics Following Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed Glioblastoma.

"Conflicts of Interest: Drs. Timothy F. Cloughesy, Albert Lai, Whitney B. Pope, and Benjamin M. Ellingson are paid consultants for Genentech, Inc., and Hoffman-La Roche, Ltd. Drs. Ellingson and Pope are also a paid consultant for MedQIA, LLC."

"We would like to thank our funding sources, including the National Brain Tumor Society Research grant (to B.M.E. and T.F.C.); National Institutes of Health, National Cancer Institute grant (NIH/NCI) 1 R21 CA167354-01 (to B.M.E.); University of California, Los Angeles (UCLA) Institute for Molecular Medicine seed grant (to B.M.E.); UCLA Radiology Exploratory Research grant (to B.M.E.); University of California Cancer Research Coordinating Committee grant (to B.M.E.); American College of Radiology Imaging Network Young Investigator Initiative grant (to B.M.E.); Art of the Brain (to T.F.C.) (http://www.artofthebrain.org/); Ziering Family Foundation (to T.F.C.); Singleton Family Foundation (to T.F.C.); the Clarance Klein Fund for Neuro-Oncology (T.F.C.); National Institutes of Health, National Institute of General Medical Sciences training grant GM08042 (to K.L.); and the UCLA Medical Scientist Training Program (to K.L.). We would also like to thank the volunteers, technologists, and research coordinators at the UCLA Brain Tumor Imaging Laboratory and the UCLA Center for Computer Vision and Imaging Biomarkers for their support."